Abstract
Background
Clinically relevant postoperative pancreatic fistula (CR-POPF) is a major source of morbidity after distal pancreatectomy. This study examined the association between postoperative opioid use and CR-POPF in the context of opioid-sparing postoperative care.
Methods
A case–control study was performed on consecutive patients who underwent distal pancreatectomy between October 2016 and April 2022 at a single institution. Patients who developed CR-POPF were compared to controls. Multivariable regression modeling was used to identify factors associated with CR-POPF.
Results
A total of 281 patients underwent 187 open, 20 laparoscopic, and 74 robotic-assisted operations. The rate of CR-POPF was 21% (n = 58). CR-POPF rate declined from 32 to 8% over the study period (p < 0.001). Median oral morphine equivalents (OME) administered on POD 0–1 and 0–3 were 94 and 129 mg, respectively, in patients who did not develop a fistula versus 130 and 180 mg in those who did (both p ≤ 0.001). POD 0–3 OME (OR 1.11, p = 0.044) was independently associated with increased odds of CR-POPF, with each additional 50 mg (equivalent to 10 tramadol pills) increasing the relative risk by 11% and absolute risk by 2%.
Conclusion
Early postoperative opioid use after distal pancreatectomy was associated with increased odds of CR-POPF. Decreasing perioperative opioid use through enhanced postoperative management is a low-cost and generalizable approach that may reduce rates of CR-POPF after distal pancreatectomy.
Similar content being viewed by others
Data Availability
Data may be made available upon reasonable request from the PI with institutional and legal approvals.
Abbreviations
- CR-POPF:
-
Clinically relevant postoperative pancreatic fistula
- OME:
-
Oral morphine equivalents
- DP:
-
Distal pancreatectomy
- ISGPS:
-
International Study Group for Pancreas Surgery
- NSQIP:
-
National Surgical Quality Improvement Program
- SO:
-
Sphincter of Oddi
- RSPCPs:
-
Risk-stratified pancreatectomy clinical pathways
- EHR:
-
Electronic health record
- POD:
-
Postoperative day
- NSAIDs:
-
Non-steroidal anti-inflammatory drugs
- BMI:
-
Body mass index
- EBL:
-
Estimated blood loss
References
Bassi C, Marchegiani G, Dervenis C, Sarr M, Abu Hilal M, Adham M et al. The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 Years After. Surgery. 2017;161(3):584-91. https://doi.org/10.1016/j.surg.2016.11.014.
Nassour I, AlMasri S, Hodges JC, Hughes SJ, Zureikat A, Paniccia A. Novel Calculator to Estimate the Risk of Clinically Relevant Postoperative Pancreatic Fistula Following Distal Pancreatectomy. J Gastrointest Surg. 2022;26(7):1436-44. https://doi.org/10.1007/s11605-022-05275-3.
Pecorelli N, Guarneri G, Palucci M, Gozzini L, Vallorani A, Crippa S et al. Early biochemical predictors of clinically relevant pancreatic fistula after distal pancreatectomy: a role for serum amylase and C-reactive protein. Surg Endosc. 2022;36(7):5431-41. https://doi.org/10.1007/s00464-021-08883-3.
Fukami Y, Saito T, Osawa T, Hanazawa T, Kurahashi T, Kurahashi S et al. Which is the best predictor of clinically relevant pancreatic fistula after pancreatectomy: drain fluid concentration or total amount of amylase? Ann Gastroenterol Surg. 2021;5(6):844-52. https://doi.org/10.1002/ags3.12471.
Callery MP, Pratt WB, Kent TS, Chaikof EL, Vollmer CM, Jr. A prospectively validated clinical risk score accurately predicts pancreatic fistula after pancreatoduodenectomy. J Am Coll Surg. 2013;216(1):1-14. https://doi.org/10.1016/j.jamcollsurg.2012.09.002.
Miller BC, Christein JD, Behrman SW, Drebin JA, Pratt WB, Callery MP et al. A multi-institutional external validation of the fistula risk score for pancreatoduodenectomy. J Gastrointest Surg. 2014;18(1):172-79; discussion 9-80. https://doi.org/10.1007/s11605-013-2337-8.
Peng YP, Zhu XL, Yin LD, Zhu Y, Wei JS, Wu JL et al. Risk factors of postoperative pancreatic fistula in patients after distal pancreatectomy: a systematic review and meta-analysis. Sci Rep. 2017;7(1):185. https://doi.org/10.1038/s41598-017-00311-8.
Andrianello S, Marchegiani G, Bannone E, Vacca P, Esposito A, Casetti L et al. Predictors of pancreatic fistula healing time after distal pancreatectomy. J Hepatobiliary Pancreat Sci. 2021;28(12):1076-88. https://doi.org/10.1002/jhbp.843.
Bag YM, Topel C, Ozdemir E, Saglam K, Sumer F, Kayaalp C. A Novel Radiological Predictor for Postoperative Pancreatic Fistula After Stapled Distal Pancreatectomy. Am Surg. 2021;87(5):725-31. https://doi.org/10.1177/0003134820952429.
Shen J, Zhang Y, Hu J, Wei R, Wu H. Albumin difference as a new predictor of pancreatic fistula following distal pancreatectomy: a retrospective study of 211 consecutive patients. Langenbecks Arch Surg. 2020;405(1):55-62. https://doi.org/10.1007/s00423-019-01849-z.
Zimmitti G, La Mendola R, Manzoni A, Sega V, Malerba V, Treppiedi E et al. Investigation of intraoperative factors associated with postoperative pancreatic fistula following laparoscopic left pancreatectomy with stapled closure: a video review-based analysis : Video-review for predictors of pancreatic leak. Surg Endosc. 2021;35(2):941-54. https://doi.org/10.1007/s00464-020-07912-x.
Halle-Smith JM, Vinuela E, Brown RM, Hodson J, Zia Z, Bramhall SR et al. A comparative study of risk factors for pancreatic fistula after pancreatoduodenectomy or distal pancreatectomy. HPB (Oxford). 2017;19(8):727-34. https://doi.org/10.1016/j.hpb.2017.04.013.
Ozyazici S, Erdogan O. Risk Factors of Postoperative Clinically Relevant Pancreatic Fistula following Distal Pancreatectomy with Stapler Closure. J Coll Physicians Surg Pak. 2021;31(10):1214-8. https://doi.org/10.29271/jcpsp.2021.10.1214.
Belyaev O, Munding J, Herzog T, Suelberg D, Tannapfel A, Schmidt WE et al. Histomorphological features of the pancreatic remnant as independent risk factors for postoperative pancreatic fistula: a matched-pairs analysis. Pancreatology. 2011;11(5):516-24. https://doi.org/10.1159/000332587.
Kowalsky SJ, Zenati MS, Dhir M, Schaefer EG, Dopsovic A, Lee KK et al. Postoperative narcotic use is associated with development of clinically relevant pancreatic fistulas after distal pancreatectomy. Surgery. 2018;163(4):747-52. https://doi.org/10.1016/j.surg.2017.10.042.
Igarashi T, Harimoto N, Matsui Y, Muranushi R, Yamanaka T, Hagiwara K et al. Association between intraoperative and postoperative epidural or intravenous patient-controlled analgesia and pancreatic fistula after distal pancreatectomy. Surg Today. 2021;51(2):276-84. https://doi.org/10.1007/s00595-020-02087-3.
Hashimoto Y, Traverso LW. After distal pancreatectomy pancreatic leakage from the stump of the pancreas may be due to drain failure or pancreatic ductal back pressure. J Gastrointest Surg. 2012;16(5):993-1003. https://doi.org/10.1007/s11605-012-1849-y.
Fazel A, Geenen JE, MoezArdalan K, Catalano MF. Intrapancreatic ductal pressure in sphincter of Oddi dysfunction. Pancreas. 2005;30(4):359-62. https://doi.org/10.1097/01.mpa.0000160278.11086.89.
Helm JF VR, Geenen JE, Hogan WJ, Dodds WJ, Toouli J, Arndorfer RC. Effects of morphine on the human sphicter of Oddi. Gut. 1988;29:1402-7.
Newhook TE, Vreeland TJ, Dewhurst WL, Arvide EM, Bruno ML, Robinson KA et al. Opioid-prescribing Practices After Oncologic Surgery: Opportunities for Improvement and a Call to Action. Ann Surg. 2020;271(2):e9-e10. https://doi.org/10.1097/SLA.0000000000003595.
Newhook TE, Dewhurst WL, Vreeland TJ, Wang X, Soliz J, Speer BB et al. Inpatient Opioid Use After Pancreatectomy: Opportunities for Reducing Initial Opioid Exposure in Cancer Surgery Patients. Ann Surg Oncol. 2019;26(11):3428-35. https://doi.org/10.1245/s10434-019-07528-z.
Newhook TE, Vreeland TJ, Dewhurst WL, Wang X, Prakash L, Feng C et al. Clinical Factors Associated With Practice Variation in Discharge Opioid Prescriptions After Pancreatectomy. Ann Surg. 2020;272(1):163-9. https://doi.org/10.1097/SLA.0000000000003112.
Kim BJ, Newhook TE, Blumenthaler A, Chiang YJ, Aloia TA, Roland CL et al. Sustained reduction in discharge opioid volumes through provider education: Results of 1168 cancer surgery patients over 2 years. J Surg Oncol. 2021;124(1):143-51. https://doi.org/10.1002/jso.26476.
Witt RG, Newhook TE, Prakash LR, Bruno ML, Arvide EM, Dewhurst WL et al. Association of Patient Controlled Analgesia and Total Inpatient Opioid Use After Pancreatectomy. J Surg Res. 2022;275:244-51. https://doi.org/10.1016/j.jss.2022.02.031.
Witt RG, Hirata Y, Prakash LR, Newhook TE, Maxwell JE, Kim MP et al. Comparative analysis of opioid use between robotic and open pancreatoduodenectomy. J Hepatobiliary Pancreat Sci. 2023;30(4):523-531. https://doi.org/10.1002/jhbp.1216.
Denbo JW, Bruno M, Dewhurst W, Kim MP, Tzeng CW, Aloia TA et al. Risk-stratified clinical pathways decrease the duration of hospitalization and costs of perioperative care after pancreatectomy. Surgery. 2018;164(3):424-31. https://doi.org/10.1016/j.surg.2018.04.014.
Denbo JW, Slack RS, Bruno M, Cloyd JM, Prakash L, Fleming JB et al. Selective Perioperative Administration of Pasireotide is More Cost-Effective Than Routine Administration for Pancreatic Fistula Prophylaxis. J Gastrointest Surg. 2017;21(4):636-46. https://doi.org/10.1007/s11605-016-3340-7.
Newton AD, Newhook TE, Bruno ML, Prakash L, Chiang YJ, Arango NP et al. Iterative Changes in Risk-Stratified Pancreatectomy Clinical Pathways and Accelerated Discharge After Pancreaticoduodenectomy. J Gastrointest Surg. 2022;26(5):1054-62. https://doi.org/10.1007/s11605-021-05235-3.
Ayabe RI PL, Bruno ML, Newhook TE, Maxwell JE, Arvide EM, Dewhurst WL et al. Differential Gains in Surgical Outcomes for High-Risk vs. Low-Risk Pancreatoduodenectomy with Successive Refinements of Risk-Stratified Care Pathways. J Am Coll Surg. 2023;237(1):4-12.https://doi.org/10.1097/XCS.0000000000000652.
Newhook TE, Vega EA, Vreeland TJ, Prakash L, Dewhurst WL, Bruno ML et al. Early postoperative drain fluid amylase in risk-stratified patients promotes tailored post-pancreatectomy drain management and potential for accelerated discharge. Surgery. 2020;167(2):442-7. https://doi.org/10.1016/j.surg.2019.09.015.
von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370(9596):1453-7. https://doi.org/10.1016/S0140-6736(07)61602-X.
The University of Texas MD Anderson Cancer Center, Department of Clinical Effectiveness. Cancer pain- Adult clinical practice algorithm, Version 12, 2020. https://www.mdanderson.org/content/dam/mdanderson/documents/for-physicians/algorithms/clinical-management/clin-management-cancer-pain-web-algorithm.pdf. Accessed 18 Oct 2022.
Patanwala AE, Duby J, Waters D, Erstad BL. Opioid conversions in acute care. Ann Pharmacother. 2007;41(2):255-66. https://doi.org/10.1345/aph.1H421.
Anderson R, Saiers JH, Abram S, Schlicht C. Accuracy in equianalgesic dosing. conversion dilemmas. J Pain Symptom Manage. 2001;21(5):397-406. https://doi.org/10.1016/s0885-3924(01)00271-8.
Pereira J, Lawlor P, Vigano A, Dorgan M, Bruera E. Equianalgesic dose ratios for opioids. a critical review and proposals for long-term dosing. J Pain Symptom Manage. 2001;22(2):672-87. https://doi.org/10.1016/s0885-3924(01)00294-9.
Ecker BL, McMillan MT, Allegrini V, Bassi C, Beane JD, Beckman RM et al. Risk Factors and Mitigation Strategies for Pancreatic Fistula After Distal Pancreatectomy: Analysis of 2026 Resections From the International, Multi-institutional Distal Pancreatectomy Study Group. Ann Surg. 2019;269(1):143-9. https://doi.org/10.1097/SLA.0000000000002491.
Miao Y, Lu Z, Yeo CJ, Vollmer CM, Jr., Fernandez-Del Castillo C, Ghaneh P et al. Management of the pancreatic transection plane after left (distal) pancreatectomy: Expert consensus guidelines by the International Study Group of Pancreatic Surgery (ISGPS). Surgery. 2020;168(1):72-84. https://doi.org/10.1016/j.surg.2020.02.018.
Sa Cunha A, Carrere N, Meunier B, Fabre JM, Sauvanet A, Pessaux P et al. Stump closure reinforcement with absorbable fibrin collagen sealant sponge (TachoSil) does not prevent pancreatic fistula after distal pancreatectomy: the FIABLE multicenter controlled randomized study. Am J Surg. 2015;210(4):739-48. https://doi.org/10.1016/j.amjsurg.2015.04.015.
Weniger M, D'Haese JG, Crispin A, Angele MK, Werner J, Hartwig W. Autologous but not Fibrin Sealant Patches for Stump Coverage Reduce Clinically Relevant Pancreatic Fistula in Distal Pancreatectomy: A Systematic Review and Meta-analysis. World J Surg. 2016;40(11):2771-81. https://doi.org/10.1007/s00268-016-3612-0.
Mungroop TH, van der Heijde N, Busch OR, de Hingh IH, Scheepers JJ, Dijkgraaf MG et al. Randomized clinical trial and meta-analysis of the impact of a fibrin sealant patch on pancreatic fistula after distal pancreatectomy: CPR trial. BJS Open. 2021;5(3):zrab001. https://doi.org/10.1093/bjsopen/zrab001.
Luu AM, Braumann C, Uhl W, Janot-Matuschek M, Herzog T. Does autologous fibrin sealant (vivostat((c))) reduce the incidence of postoperative pancreatic fistula after distal pancreatectomy? - a matched pairs analysis. Acta Chir Belg. 2021;121(1):16-22. https://doi.org/10.1080/00015458.2019.1658354.
Deng Y, He S, Cheng Y, Cheng N, Gong J, Gong J et al. Fibrin sealants for the prevention of postoperative pancreatic fistula following pancreatic surgery. Cochrane Database Syst Rev. 2020;3:CD009621. https://doi.org/10.1002/14651858.CD009621.pub4.
Afghani E, Lo SK, Covington PS, Cash BD, Pandol SJ. Sphincter of Oddi Function and Risk Factors for Dysfunction. Front Nutr. 2017;4:1. https://doi.org/10.3389/fnut.2017.00001.
Toouli J. Sphincter of Oddi: Function, dysfunction, and its management. J Gastroenterol Hepatol. 2009;24 Suppl 3:S57-62. https://doi.org/10.1111/j.1440-1746.2009.06072.x.
Sharma SS. Sphincter of Oddi dysfunction in patients addicted to opium: an unrecognized entity. Gastrointest Endosc. 2002;55(3):427-30. https://doi.org/10.1067/mge.2002.121600.
Mousavi S, Toussy J, Zahmatkesh M. Opium addiction as a new risk factor of sphincter of Oddi dysfunction. Med Sci Monit. 2007;13(11):CR528-31.
Thompson DR. Narcotic analgesic effects on the sphincter of Oddi: a review of the data and therapeutic implications in treating pancreatitis. Am J Gastroenterol. 2001;96(4):1266-72. https://doi.org/10.1111/j.1572-0241.2001.03536.x.
Goff JS. The human sphincter of Oddi. Physiology and pathophysiology. Archives of internal medicine. 1988;148(12):2673-2677. PMID: 3058076.
Radnay PA, Duncalf D, Novakovic M, Lesser ML. Common bile duct pressure changes after fentanyl, morphine, meperidine, butorphanol, and naloxone. Anesthesia and analgesia. 1984;63(4):441-4. https://doi.org/10.1213/00000539-198404000-00012.
Sherman S, Lehman GA. Opioids and the sphincter of Oddi. Gastrointest Endosc. 1994;40(1):105-6. https://doi.org/10.1016/s0016-5107(94)70027-3.
Akbarali HI, Inkisar A, Dewey WL. Site and mechanism of morphine tolerance in the gastrointestinal tract. Neurogastroenterol Motil. 2014;26(10):1361-7. https://doi.org/10.1111/nmo.12443.
Leedham JA, Jian-Qiang K, Taylor DA, Johnson SM, Fleming WW. Membrane potential in myenteric neurons associated with tolerance and dependence to morphine. The Journal of pharmacology and experimental therapeutics. 1992;263(1):15-9.
Rezvani A, Huidobro-Toro JP, Hu J, Way EL. A rapid and simple method for the quantitative determination of tolerance development to opiates in the guinea-pig ileum in vitro. J Pharmacol Exp Ther. 1983;225(2):251-55.
Hackert T, Klaiber U, Hinz U, Kehayova T, Probst P, Knebel P et al. Sphincter of Oddi botulinum toxin injection to prevent pancreatic fistula after distal pancreatectomy. Surgery. 2017;161(5):1444-50. https://doi.org/10.1016/j.surg.2016.09.005.
Rieder B, Krampulz D, Adolf J, Pfeiffer A. Endoscopic pancreatic sphincterotomy and stenting for preoperative prophylaxis of pancreatic fistula after distal pancreatectomy. Gastrointest Endosc. 2010;72(3):536-42. https://doi.org/10.1016/j.gie.2010.04.011.
Abe N, Sugiyama M, Suzuki Y, Yamaguchi Y, Yanagida O, Masaki T et al. Preoperative endoscopic pancreatic stenting for prophylaxis of pancreatic fistula development after distal pancreatectomy. Am J Surg. 2006;191(2):198-200. https://doi.org/10.1016/j.amjsurg.2005.07.036.
Frozanpor F, Lundell L, Segersvard R, Arnelo U. The effect of prophylactic transpapillary pancreatic stent insertion on clinically significant leak rate following distal pancreatectomy: results of a prospective controlled clinical trial. Ann Surg. 2012;255(6):1032-6. https://doi.org/10.1097/SLA.0b013e318251610f.
Marchegiani G, Barreto SG, Bannone E, Sarr M, Vollmer CM, Connor S et al. Postpancreatectomy Acute Pancreatitis (PPAP): Definition and Grading From the International Study Group for Pancreatic Surgery (ISGPS). Ann Surg. 2022;275(4):663-72. https://doi.org/10.1097/SLA.0000000000005226.
Wilson RB. Morpheus and the Underworld-Interventions to Reduce the Risks of Opioid Use After Surgery: ORADEs, Dependence, Cancer Progression, and Anastomotic Leakage. J Gastrointest Surg. 2019;23(6):1240-9. https://doi.org/10.1007/s11605-019-04167-3.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Meetings/Presentations.
This project was presented as an oral presentation at the Americas Hepato-Pancreato-Biliary Association (AHPBA) 2023 Annual Meeting and as a long oral presentation at the 2023 Pancreas Club Meeting.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Boyev, A., Prakash, L.R., Chiang, YJ. et al. Postoperative Opioid Use Is Associated with Increased Rates of Grade B/C Pancreatic Fistula After Distal Pancreatectomy. J Gastrointest Surg 27, 2135–2144 (2023). https://doi.org/10.1007/s11605-023-05751-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11605-023-05751-4